Deploying Point-of-Care Testing (POCT) and Decentralized Diagnostic Platforms for Rapid Clinical Decision-Making in the 2026 Metabolic Testing Sector
In early 2026, "Point-of-Care Testing" (POCT) is decentralizing metabolic health assessments by moving "Diagnostic Precision" from the central laboratory directly to the "Patient’s Bedside" or "Local Pharmacy." These 2026 "Handheld Analyzers" utilize "Lab-on-a-Chip Technology" to provide "Real-Time Measurement" of "Blood Glucose, Lactate, and Lipid Panels" within seconds, allowing for...
0 Комментарии 0 Поделились 20 Просмотры 0 предпросмотр